Expert: MDMA-Assisted Therapy Has Potential Benefits for Women with Hypoactive Sexual Desire Disorder

Kelsey Ramsden, CEO of Mind Cure Health, said research into the use of MDMA-assisted therapy could have a huge impact on the treatment of female hypoactive sexual desire disorder.

In part 1 of an interview with Pharmacy Times, Kelsey Ramsden, CEO of Mind Cure Health, said research into the use of MDMA-assisted therapy could have a huge impact on the treatment of female hypoactive sexual desire disorder.

Mind Cure Health has launched The Desire Project, which is investigating the potential use of MDMA-assisted psychotherapy for the treatment of female hypoactive sexual desire disorder. In the interview, Ramsden discussed how sexual health is directly linked with mental health, how MDMA-assisted psychotherapy could be used to treat the disorder, and why the Desire Project is directly focusing on women.